- Regents approve donor-funded medical building at UNLV (reviewjournal.com)
The Nevada System of Higher Education Board of Regents Thursday approved the broad framework for a new, privately-funded medical school building at UNLV, subject to mutually-agreed conditions with the project’s donors that require construction to start by Feb. 1 of next year...“If we are to become a state of the art medical school that innovates and changes the health care landscape in Southern Nevada, we need facilities to make that goal a reality,” Marta Meana, UNLV’s acting president, told the board before the vote. “What we have before us today is a once in a generation opportunity thanks to the remarkable generosity of a group of community members who have been strongly invested in this medical school since its inception, and in UNLV for decades.”...Critics of the deal expressed concerns that NSHE and UNLV potentially would have to surrender to the donor corporation too much control over the operation, management and programming.,,READ MORE
- Patients, experts testify about the impact of rising drug costs at first meeting of prescription price committee (thenevadaindependent.com)
...the first meeting of a committee focused on assessing prescription drug pricing...The Committee to Conduct an Interim Study Concerning the Cost of Prescription Drugs was formed to look into the overall cost of prescription drugs in Nevada and how they compare to other states. Additionally, members will look at the impact of rebates, price reductions, and other remuneration from manufacturers on the costs of prescription drugs, and identify opportunities to lower prescription drug costs...The committee was formed as a result of SB276, which passed during the 2019 legislative session...READ MORE
- This Week in Managed Care: January 31, 2020 (ajmc.com)
Matthew Gavidia, welcome to This Week in Managed Care from the Managed Markets News Network
- Fake drugs: Unharmonized legislation threatens the lives of African patients (in-pharmatechnologist.com)
Although control measures are applied, falsified medicines are present in the supply chain in Niger, with solutions requiring cross-country collaboration, says the country’s Ministry of Health...The spotlight was put on the topic of falsified medicines earlier this month with the signing of the Lomé Initiative, a political declaration under which the governments of seven African countries agreed to act to fight the issue, and improve access to quality medicines for African populations...the smuggling of fake drugs occurring at the country’s borders is the main weak point in the supply chain...harmonization of the legislation...can and needs to be achieved with the establishment of the African Medicines Agency, which would be the African equivalent of the European Medicines Agency, in charge of the evaluation and supervision of medicinal products...READ MORE
- OneRepublic frontman buys a Walgreens building on Las Vegas Strip (reviewjournal.com)
Tedder (Ryan Tedder ) confirmed...he teamed up to buy the Walgreens building across from Park MGM, and that his investors on the deal included DJ duo the Chainsmokers...The $38 million sale by Walgreen Co., which bought the building in June from its former landlord for $30 million and flipped it, closed last month, property records show...Drugstores on tourist-choked Las Vegas Boulevard are big business, commanding outsize rents, strong retail sales and, as the recent purchase shows, high property values...Illinois-based Walgreen Co. had listed its 15,000-square-foot building on Las Vegas Boulevard between Tropicana and Harmon avenues for $40 million...READ MORE
- Top 10 medication hazards of 2019 include selecting wrong drug on computer screens (fiercehealthcare.com)4 in 10 patients harmed by medical errors in primary and outpatient settings (fiercehealthcare.com)CHALLENGES AND OPPORTUNITIES FOR THE IMPROVEMENT OF HEALTH SYSTEMS (fidhs.org)
Providers are making an increasing number of mistakes selecting the wrong medication for patients on their computer screens or tablets, according to the Institute for Safe Medication Practices ...The problem is that physicians and other providers select the wrong medication after entering the first few letters of the drug name into their technology screens, said the institute, which released its list of the top 10 most persistent medication errors and hazards it uncovered in 2019...READ MORE
- January 31 Pharmacy Week in Review (pharmacytimes.com)
Nicole Grassano, PTNN, Pharmacy Week in Review, this weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
- Gilead working with China to test Ebola drug as new coronavirus treatment (reuters.com)China lab seeks patent on use of Gilead's coronavirus treatment (reuters.com)
Gilead Sciences Inc said...it provided its experimental Ebola therapy for use in a small number of patients with the coronavirus…The company said it was also expediting laboratory testing of the antiviral drug, remdesivir, against samples of the new coronavirus…Johnson & Johnson...joined a growing list of drugmakers to begin work on developing a vaccine for the virus...Co-Diagnostics Inc said...initial verification of its screening test designed to identify the presence of the coronavirus was successful...READ MORE
- U.S. declares coronavirus health emergency, bars foreign nationals who visited China (reuters.com)
The Trump administration...declared a public health emergency...and announced the extraordinary step of barring entry to the United States of foreign nationals who have recently visited China...In addition, U.S. citizens who have traveled within the past two weeks to China’s Hubei Province - epicenter of the coronavirus epidemic - will be subject to a mandatory quarantine of 14 days, the incubation period of the virus, officials said...READ MORE
- Rule on Reporting Clinical Trial Results Often Violated (ptcommunity.com)White males overrepresented in clinical trials for first-time cancer treatment (outsourcing-pharma.com)
Less than half of clinical trial results are reported promptly on the U.S. trial registry ClinicalTrials.gov despite federal requirements, according to a recent study published in The Lancet...U.S. regulations that took effect in January 2017 require clinical trials to report results on ClinicalTrials.gov within one year of completion. But just 41% of trials followed the rules, and one in three trials remains unreported. Trials with nonindustry sponsors (such as universities, hospitals, and governments) are far more likely to breach the rules than trials sponsored by industry—with trials sponsored by the U.S. government least likely to post results on time...READ MORE










